Cargando…
Detection of genomic mutations in blood and urine free circulating tumour DNA in patients with inoperable and metastatic lung adenocarcinoma harbouring an EGFR mutation in tissue: a UK pilot study
The development of methodologies to analyse circulating tumour DNA (ctDNA) in the blood or urine of cancer patients provides an invaluable resource that can be used for diagnosis and prognosis and to evaluate response to treatments. Lung cancer has seen in the last years a revolution in treatment st...
Autores principales: | Brooks, Helen, Li, Ling, Addeo, Alfredo, Stevens, Megan, Comins, Charles, Oltean, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354425/ https://www.ncbi.nlm.nih.gov/pubmed/37476385 http://dx.doi.org/10.3389/fonc.2023.1197037 |
Ejemplares similares
-
Micropapillary: A component more likely to harbour heterogeneous EGFR mutations in lung adenocarcinomas
por: Cai, Yi-Ran, et al.
Publicado: (2016) -
Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations
por: Hatakeyama, Keiichi, et al.
Publicado: (2018) -
Acquisition of T790M resistance mutation in a patient with advanced adenocarcinoma harbouring uncommon EGFR mutations: a case report and literature review
por: Hakozaki, Taiki, et al.
Publicado: (2019) -
The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy
por: Friedlaender, Alex, et al.
Publicado: (2021) -
Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations
por: Holleman, Marscha S., et al.
Publicado: (2019)